Legal Representation
Attorney
Changhoon Lee
USPTO Deadlines
Next Deadline
In Grace Period
Section 8 & 9 Renewal Due (Principal Register) (Based on registration date 20151103)
Due Date
November 03, 2025
Grace Period Ends
May 03, 2026
Application History
41 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Nov 3, 2024 | REM2 | E | COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED | Loading... |
| Apr 18, 2022 | NAS8 | E | NOTICE OF ACCEPTANCE OF SEC. 8 - E-MAILED | Loading... |
| Apr 18, 2022 | 8.OK | O | REGISTERED - SEC. 8 (6-YR) ACCEPTED | Loading... |
| Apr 18, 2022 | APRE | A | CASE ASSIGNED TO POST REGISTRATION PARALEGAL | Loading... |
| Oct 26, 2021 | ES8R | I | TEAS SECTION 8 RECEIVED | Loading... |
| Nov 3, 2020 | REM1 | E | COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED | Loading... |
| Nov 3, 2015 | R.PR | A | REGISTERED-PRINCIPAL REGISTER | Loading... |
| Sep 26, 2015 | SUNA | E | NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED | Loading... |
| Sep 25, 2015 | CNPR | P | ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED | Loading... |
| Sep 8, 2015 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
| Sep 8, 2015 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
| Sep 1, 2015 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED | Loading... |
| Aug 27, 2015 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED | Loading... |
| Aug 27, 2015 | GNRT | O | NON-FINAL ACTION E-MAILED | Loading... |
| Aug 27, 2015 | CNRT | W | SU - NON-FINAL ACTION - WRITTEN | Loading... |
| Aug 4, 2015 | SUPC | I | STATEMENT OF USE PROCESSING COMPLETE | Loading... |
| Jul 9, 2015 | IUAF | S | USE AMENDMENT FILED | Loading... |
| Aug 4, 2015 | AITU | A | CASE ASSIGNED TO INTENT TO USE PARALEGAL | Loading... |
| Jul 9, 2015 | EISU | I | TEAS STATEMENT OF USE RECEIVED | Loading... |
| Jan 13, 2015 | NOAM | E | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | Loading... |
| Nov 18, 2014 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | Loading... |
| Nov 18, 2014 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
| Oct 29, 2014 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | Loading... |
| Oct 16, 2014 | PREV | O | LAW OFFICE PUBLICATION REVIEW COMPLETED | Loading... |
| Oct 16, 2014 | ALIE | A | ASSIGNED TO LIE | Loading... |
| Sep 29, 2014 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
| Sep 2, 2014 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
| Sep 1, 2014 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
| Sep 1, 2014 | ERFR | I | TEAS REQUEST FOR RECONSIDERATION RECEIVED | Loading... |
| Jul 16, 2014 | GNFN | O | NOTIFICATION OF FINAL REFUSAL EMAILED | Loading... |
| Jul 16, 2014 | GNFR | O | FINAL REFUSAL E-MAILED | Loading... |
| Jul 16, 2014 | CNFR | R | FINAL REFUSAL WRITTEN | Loading... |
| May 31, 2014 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
| May 31, 2014 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
| May 31, 2014 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED | Loading... |
| Mar 21, 2014 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED | Loading... |
| Mar 21, 2014 | GNRT | F | NON-FINAL ACTION E-MAILED | Loading... |
| Mar 21, 2014 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
| Mar 15, 2014 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Dec 19, 2013 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
| Dec 6, 2013 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 042
Research and development of pharmaceuticals for the treatment of cancer; pharmaceutical products development; pharmaceutical research and development; consulting services in the fields of pharmaceutical research and development; pharmaceutical product evaluation; consultancy pertaining to pharmacology; research and development in the field of medical products and pharmaceuticals; medical research
First Use Anywhere:
Sep 18, 2013
First Use in Commerce:
Sep 18, 2013
Classification
International Classes
042
Disclaimers
The following terms have been disclaimed and are not claimed as part of the trademark:
Specific Disclaimer
"THERIAC"